Ocugen, Inc.
Long

OCGN Rev Strat Month

292
Covaxin Covid Vaccine approval decision expected Oct 5th. High and tight on the monthly. Over $7.12 triggers rev strat month. Used to be somebody! #TheStrat

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.